임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

22건 표시

2상모집 중단 (진행 중)· Mantle Cell Lymphoma
GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma
협력: 애브비, 일라이 릴리, 로슈
상세 →NCT06522386
2상모집 중단 (진행 중)· Urothelial Carcinoma
Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)
리드: 애브비
상세 →NCT06632951
2상모집 중단 (진행 중)· Atopic Dermatitis
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis
리드: 애브비
상세 →NCT06718101
2상모집 중단 (진행 중)· Ulcerative Colitis
A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis
리드: 애브비
상세 →NCT06257875
2상모집 중단 (진행 중)· Unresectable Metastatic Colorectal Cancer
Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab
리드: 애브비
상세 →NCT06107413
2상모집 중단 (진행 중)· Chronic Myeloid Leukemia
Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)
협력: 애브비
상세 →NCT05768711
2상모집 중단 (진행 중)· Hepatocellular Carcinoma
Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)
리드: 애브비
상세 →NCT05822752
2상모집 중단 (진행 중)· Chronic Myeloid Leukemia
Venetoclax After TKI to Target Persisting Stem Cells in CML
협력: 애브비
상세 →NCT05701215
2상모집 중단 (진행 중)· Acute Myeloid Leukemia (AML)
Venetoclax in Combination With 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy
협력: 애브비
상세 →NCT05833438
2상모집 중단 (진행 중)· High Grade Ovarian Cancer
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer
리드: 애브비
상세 →NCT05456685
2상모집 중단 (진행 중)· Diffuse Large B-Cell Lymphoma
A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma
협력: 애브비
상세 →NCT05451810
2상모집 중단 (진행 중)· Non-Hodgkin Lymphoma
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
협력: 애브비
상세 →NCT05283720
2상모집 중단 (진행 중)· Hidradenitis Suppurativa
A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy
리드: 애브비
상세 →NCT05139602
2상모집 중단 (진행 중)· Acute Myeloid Leukemia
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
협력: 애브비
상세 →NCT04801797
2상모집 중단 (진행 중)· Marginal Zone Lymphoma
A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma
협력: 애브비
상세 →NCT04416451
2상모집 중단 (진행 중)· Diabetic Retinopathy (DR)
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)
리드: 애브비
상세 →NCT04567550
2상모집 중단 (진행 중)· Neovascular Age-Related Macular Degeneration (nAMD)
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)
리드: 애브비
상세 →NCT04514653
2상모집 중단 (진행 중)· Waldenstrom Macroglobulinemia
Ibrutinib + Venetoclax in Untreated WM
협력: 애브비
상세 →NCT04273139
2상모집 중단 (진행 중)· Prostate Cancer
Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer
협력: 애브비
상세 →NCT04197141
2상모집 중단 (진행 중)· Non-small Cell Lung Cancer
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer
리드: 애브비
상세 →NCT03539536
2상모집 중단 (진행 중)· Multiple Myeloma
A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma
리드: 애브비 · 협력: 얀센(J&J)
상세 →NCT03314181
2상모집 중단 (진행 중)· Multiple Myeloma
Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)
리드: 애브비 · 협력: 로슈
상세 →NCT02899052

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.